Can Stem Cell Therapy Improve Movement in Children with Cerebral Palsy?

In this episode, we explore whether stem cell therapy can help improve movement, muscle control, and mobility in children with cerebral palsy and what current research really says.

You’ll learn:

• What cerebral palsy is and how it affects movement, muscle tone, and coordination
• How stem cell therapy works and why researchers are studying it for mobility improvement
• What clinical trials reveal about muscle control, balance, and walking ability
• The different types of stem cells used, including umbilical cord blood and bone marrow
• Why are results still limited due to small study groups and varying methods
• Potential risks, safety concerns, and why regulated clinical trials are essential
• What families should consider before exploring stem cell therapy as a treatment option

While stem cell therapy shows promising signs in early research, it remains an emerging treatment. This episode helps families understand the balance between hope and caution, and why physical therapy continues to be the foundation of care for children with cerebral palsy.

Blog Link: Can Stem Cell Therapy Improve Movement in Children with Cerebral Palsy?

Transcript

SPEAKER_00 0:00

Welcome to the Sorona Cell Podcast.

SPEAKER_01 0:02

Glad to be here today.

SPEAKER_00 0:03

So if a child breaks a bone, a doctor sets it, puts a cast on it, and then you know it heals. The physical hardware is broken and we just fix it.

SPEAKER_01 0:10

Right. It's a very straightforward mechanical sort of fix.

SPEAKER_00 0:12

Exactly. But what happens when the physical hardware, like the muscles and the bones, is fundamentally fine, but the biological software running it has a totally scrambled signal.

SPEAKER_01 0:23

That is uh well, that's really the core of what we're getting into today.

SPEAKER_00 0:26

Aaron Powell Yeah. Today we are taking a deep dive into one of the most complex, emotional, and frankly intensely debated questions in modern medicine. Can stem cell therapy actually improve movement in children with cerebral palsy?

SPEAKER_01 0:41

It's a massive question, and it carries an immense amount of weight for families, especially because they're trying to navigate this landscape filled with both, you know, incredible scientific breakthroughs and unfortunately a whole lot of misleading information out there.

SPEAKER_00 0:55

Absolutely. So to get some clarity for you listening today, we are pulling from a stack of current medical sources, specifically clinical literature and research summaries detailing the protocols at Cyrona Cell.

SPEAKER_01 1:06

Which is really helpful because we need a concrete example of how this is actually done in the real world.

SPEAKER_00 1:11

Right. And for some context, Cyrona Cell is a doctor-led stem cell therapy and regenerative medicine center. They are based in Kuala Lumpur, Malaysia. They treat local patients, but they also see a really high volume of international families flying in from places like Australia and uh the Middle East to undergo these structured programs.

SPEAKER_01 1:31

Our mission today is to explore the science of regenerative medicine using really clear, accessible language. We are focusing entirely on honest, structured, and most importantly, scientifically grounded information.

SPEAKER_00 1:44

Yeah, we aren't looking at quick fix promises today.

SPEAKER_01 1:47

Exactly. We are taking a clear-eyed look at the underlying biology, what the clinical trials are actually demonstrating, and you know what families realistically need to know before considering this path at all.

SPEAKER_00 1:58

Okay, so before we jump into the cutting-edge cellular science, we really have to understand the physical reality of cerebral palsy or CP.

SPEAKER_01 2:07

Right. Because if you don't understand the condition, the treatment won't make any sense.

SPEAKER_00 2:11

The sources describe it basically as a neurological disconnect. So instead of a broken bone, I want you to think of the neural pathways between the brain and the muscles like um like a major highway.

SPEAKER_01 2:23

I like that analogy. Or even, you know, think of it like a remote control in a television set.

SPEAKER_00 2:27

Oh yeah, the the TV and the remote. So the TV, which is the muscles, is fundamentally fine. The parts are all in working order. But the remote control, the brain suffered an injury before, during, or shortly after birth.

SPEAKER_01 2:39

Right. And that injury essentially scrambles the signal. So the TV is just receiving static.

SPEAKER_00 2:44

Aaron Powell, which means the signals commanding the muscles to relax or contract just can't get through properly. This neurological traffic jam leads directly to the physical symptoms we see, right?

SPEAKER_01 2:54

Exactly. You get chronic muscle stiffness, severe balance issues, uncoordinated movements, and uh significant difficulty walking.

SPEAKER_00 3:02

Aaron Powell And traditionally, the medical approach is really just focused on managing that traffic jam. We use intensive physical therapy, occupational therapy, muscle relaxance, and sometimes even orthopedic surgery to work around the problem.

SPEAKER_01 3:16

Aaron Powell Yeah, we try to maximize whatever pathways are still open. But as you mentioned earlier, you can't just put a physical cast on a scrambled neural signal.

SPEAKER_00 3:25

Aaron Powell Which is exactly why regenerative medicine and specifically stem cell therapy is just dominating the conversation right now.

SPEAKER_01 3:32

Right. Because when we introduce stem cells into this environment, we are looking at a fundamentally different approach to the injury itself. But um it is crucial to understand how they actually work.

SPEAKER_00 3:44

Aaron Powell Because the popular perception is quite different from the biological reality, right?

SPEAKER_01 3:48

Oh, completely different. The immediate assumption most people have is that stem cells act like literal replacement parts.

SPEAKER_00 3:54

Yeah, I think people picture, you know, injecting them and they instantly turn into brand new brain cells to rebuild that collapsed highway bridge overnight.

SPEAKER_01 4:01

Aaron Powell Right. But looking through the clinical literature, that is not at all what is happening under the microscope. They are not simply new asphalt being poured over the road.

SPEAKER_00 4:11

So what are they doing then?

SPEAKER_01 4:13

Well, the science suggests a much more dynamic interactive process. Researchers hypothesize that these cells function much more like uh microscopic construction managers sent to a disaster site.

SPEAKER_00 4:25

Oh, construction managers, that's interesting.

SPEAKER_01 4:27

Yeah, so when they arrive at the damaged area of the brain, their first job is to assess the hostile environment. They release specific proteins called cytokines that actively reduce inflammation.

SPEAKER_00 4:38

So they're almost like biological firefighters.

SPEAKER_01 4:40

Exactly. They cool down the surrounding tissue and create a safe space for the body's existing healthy cells to actually operate.

SPEAKER_00 4:48

Wait, so they aren't necessarily doing all the rebuilding themselves. They're basically just changing the chemical environment.

SPEAKER_01 4:53

Yes. They calm the inflammation and then they start signaling the local cells to get to work. We call this peracrine signaling.

SPEAKER_00 5:00

Peracrine signaling, okay.

SPEAKER_01 5:02

They secrete growth factors that improve communication between the existing healthy brain cells. And over time, this optimized cellular environment may encourage the brain to form entirely new connections.

SPEAKER_00 5:15

Like building new neural decors around that original collapsed bridge.

SPEAKER_01 5:19

Exactly. And to achieve this, the researchers are specifically looking at cell source from umbilical cord blood and bone marrow, testing their capacity to perform this kind of advanced cellular support in children with CP.

SPEAKER_00 5:32

Okay, so if these construction managers have this incredible theoretical potential to go in, cool down the inflammation, and orchestrate the building of new neural pathways, what actually happens when we put this into practice?

SPEAKER_01 5:45

Right. Let's look at the actual clinical trials. Because when we examine the real-world data, we do see genuinely promising, measurable findings.

SPEAKER_00 5:53

What kind of findings?

SPEAKER_01 5:54

Well, in several controlled studies, pediatric physical therapists are reporting that children show improved muscle tone. We're seeing quantifiable improvements in balance, better overall motor scores, and small but uh very significant gains in coordination and walking ability.

SPEAKER_00 6:09

I really want to pause on that for a second because reading those results, better motor scores, improved balance, a child finally being able to coordinate their movements, I mean, it sounds incredible.

SPEAKER_01 6:20

It is incredible. It offers a lot of hope.

SPEAKER_00 6:22

But I have to push back here because I'm sure you listening are wondering the exact same thing right now. If we are seeing a child open a ham that has been clenched for years due to spasticity, why isn't this just the standard of care in every pediatric hospital on the planet right now? What is the catch?

SPEAKER_01 6:40

That is the central tension in this entire field. It really is. The reason it is not the universal standard of care lies in the limitations of the current data.

SPEAKER_00 6:49

Okay, so the data isn't solid yet.

SPEAKER_01 6:50

The trials are incredibly promising, but they are also highly fragmented. Right now, studies often use very small groups of patients. And uh more importantly, researchers across different institutions are using entirely different methodologies.

SPEAKER_00 7:05

Ah, so it's not consistent.

SPEAKER_01 7:06

Not at all. One trial might use a really high dose of bone marrow cells delivered intravenously, while another uses a low dose of umbilical cord cells delivered via a spinal injection.

SPEAKER_00 7:17

Oh wow. So it's basically impossible to compare the outcomes. You can't definitively say treatment A works when half the researchers are using treatment B, C, and D.

SPEAKER_01 7:26

Exactly. It's a completely unstandardized landscape right now.

SPEAKER_00 7:29

Yeah.

SPEAKER_01 7:29

The scientific community requires massive, standardized, double-blind trials to definitively prove efficacy and establish universal protocols.

SPEAKER_00 7:38

And I imagine there are risks involved, too.

SPEAKER_01 7:40

Aaron Powell Yes, you have to add in the known risks. While generally well tolerated, some children in these trials do experience side effects like mild fevers or headaches following the therapy.

SPEAKER_00 7:50

Aaron Powell So because of these variables, the inconsistent trial designs and the ongoing monitoring of safety, the broader medical community still officially classifies stem cell therapy for CP as an emerging treatment.

SPEAKER_01 8:02

Right, emerging, not standard.

SPEAKER_00 8:04

So because the clinical trial methods vary so wildly out there in the broader world, where and how the cells are sourced, processed, and administered becomes the absolute most critical factor for any family considering this.

SPEAKER_01 8:15

Absolutely. The clinic you choose changes everything.

SPEAKER_00 8:18

And this really explains why our sources spend so much time detailing the rigorous, almost obsessive standardization protocols at Cyrona Cell.

SPEAKER_01 8:27

Aaron Powell Well, when a treatment is classified as emerging, the environment in which it is delivered just has to be exceptionally controlled. You cannot have variables in the laboratory when you were trying to measure clinical outcomes in a patient.

SPEAKER_00 8:39

Right. So let's break down what those controls actually look like because the literature throws a lot of heavy acronyms at us. Cyrona Cell focuses specifically on what they call early passage WJMSCs.

SPEAKER_01 8:51

Yes, early passage WJMSCs.

SPEAKER_00 8:54

Which stands for Wharton's Jelly Mesenchymal Stem Cells. So for you listening, Wharton's jelly is a tissue found inside the umbilical cord. And mesenchymal stem cells are the specific type of cells known for that construction manager signaling we talked about earlier.

SPEAKER_01 9:08

Right. Those are the exact cells releasing the cytokines and growth factors.

SPEAKER_00 9:12

But the really crucial part of that phrase is early passage. Is this essentially like ensuring a high-end restaurant uses only the freshest, most strictly farm-to-table ingredients in a health-inspected kitchen, avoiding the sort of um mystery meat found elsewhere?

SPEAKER_01 9:27

Aaron Powell That is a perfect analogy, actually. Yes. Early passage is arguably the most important metric for cell quality. How so? Well, when cells are cultivated in a lab, they replicate. Each time they replicate, it is called a passage. If you passage cells too many times, essentially like photocopying a photocopy over and over again, they lose their vitality.

SPEAKER_00 9:47

Ah, so the copy gets blurrier and weaker every time.

SPEAKER_01 9:50

Exactly. They become exhausted and much less effective at signaling and reducing inflammation. By strictly utilizing early passage cells, Cerona cell ensures they are administering young, robust, highly active cells that still have their full therapeutic potential intact.

SPEAKER_00 10:05

And to protect those delicate, robust cells, the clinic operates under CGMP and ISO 9001 certified quality systems alongside BSL2 laboratory standards.

SPEAKER_01 10:17

Which is a lot of letters and numbers, I know.

SPEAKER_00 10:18

Right. So instead of just rattling off acronyms, let's look at what that practically means. CGMP means current good manufacturing practice. BSL2 is biological safety level two.

SPEAKER_01 10:31

And this isn't just about passing a basic health inspection. This level of environmental control, the air filtration, the sterility protocols, the rigorous identity checks on every single batch, it is entirely about preventing contamination.

SPEAKER_00 10:44

Contamination that could just destroy the viability of those cells before they ever reach the patient.

SPEAKER_01 10:49

Precisely. The clinical efficacy of the treatment is inextricably linked to the sterility of the lab. If the cell viability drops due to poor handling, the therapeutic benefit just vanishes.

SPEAKER_00 11:00

And this rigorous standardization extends directly to their ethical sourcing protocols as well, right? The literature is very explicit about where these cells actually come from.

SPEAKER_01 11:07

Very explicit, yes. They utilize umbilical cord-derived cells sourced exclusively from healthy term deliveries and only ever with explicit documented donor consent.

SPEAKER_00 11:17

Aaron Powell And they strictly do not use embryonic stem cells, nor do they use experimental pluripotent stem cells in their clinical services.

SPEAKER_01 11:25

Right. They are relying on cells with a proven safety profile and a known biological mechanism. Pluripotent cells, while scientifically fascinating in a research setting, well, they carry unpredictable risks.

SPEAKER_00 11:39

Risks that are completely inappropriate for clinical application in children today.

SPEAKER_01 11:43

Absolutely.

SPEAKER_00 11:43

You know, that hypervigilance regarding safety and ethical boundaries isn't just a clinical mandate for them. It seems baked into their entire philosophy. How do you mean? Well, I found this fun, memorable fact. You actually see that ethos reflected in the name of the clinic itself. Sorona is derived from a Celtic goddess associated with health, healing, and protection.

SPEAKER_01 12:05

Oh wow. I didn't know that. That's a great detail.

SPEAKER_00 12:08

Right. It symbolizes an ethos of providing safe, heavily vetted, science-led care. It acts as a protective barrier against the kind of unregulated quick fix experimentation that unfortunately exists in the broader market.

SPEAKER_01 12:20

And that philosophy of protection really dictates their physical delivery methods as well. Standard protocols at Sorona cell rely on minimally invasive administration.

SPEAKER_00 12:29

Aaron Powell So no big surgeries.

SPEAKER_01 12:30

No, absolutely not. The treatments are delivered via IV infusions and, where clinically appropriate, targeted injections. There is absolutely no open surgery involved in these standard programs.

SPEAKER_00 12:42

Aaron Powell No, I was looking through the bios of the medical team responsible for administering these treatments and monitoring the patients, and um I noticed something that genuinely surprised me.

SPEAKER_01 12:51

What was that?

SPEAKER_00 12:52

They have a highly multidisciplinary team, physicians with backgrounds in internal medicine, neurology, and rehabilitation, but they also prominently feature sports medicine specialists.

SPEAKER_01 13:03

Ah, yes.

SPEAKER_00 13:04

Which, you know, for a pediatric neurological condition like cerebral palsy, my mind immediately goes to neurosurgeons or pediatricians, not sports rehab.

SPEAKER_01 13:13

It seems counterintuitive at first glance. I completely agree. Yeah. But it makes perfect clinical sense when you actually consider the physical realities of the condition. Trevor Burrus, Jr.

SPEAKER_00 13:21

Because it's all about movement.

SPEAKER_01 13:22

Right. Sports medicine is fundamentally the science of biomechanics, muscle function, joint stability, and mobility recovery. Because cerebral palsy primarily manifests as a severe disruption to movement and muscle control, having specialists who deeply understand how to rehabilitate the physical body is a massive advantage.

SPEAKER_00 13:41

They are the experts in taking a damaged physical system and optimizing it for movement, right? Correcting biomechanical imbalances.

SPEAKER_01 13:49

Exactly. The neurologist understands the scrambled signal in the brain, but the sports medicine and rehabilitation specialists understand how to retrain the muscle to respond once that signal begins to clear up.

SPEAKER_00 14:00

It really highlights their commitment to clinical depth, treating the whole physiological system, not just, you know, injecting cells and hoping for the best.

SPEAKER_01 14:08

Exactly. Which actually brings us to the most crucial part of this entire deep dive.

SPEAKER_00 14:13

Yes, we've looked at the biology, the clinical trial data, and the massive laboratory infrastructure required to do this safely. So what is the ultimate practical takeaway for you, the listener, or any family trying to navigate this incredibly emotional landscape?

SPEAKER_01 14:27

The single most vital insight from the literature, and a core tenet of Saronacell's philosophy, is that regenerative medicine must be viewed as an adjunct.

SPEAKER_00 14:36

An adjunct, meaning a supplement.

SPEAKER_01 14:38

Yes. It is supplement to traditional care. It is absolutely not a replacement for specialist oversight, intensive physical therapy, emergency medical treatment, or necessary orthopedic surgery.

SPEAKER_00 14:50

So just to be incredibly clear, stem cell therapy is not a cure for cerebral palsy.

SPEAKER_01 14:55

No, it is not a cure. The initial brain injury is permanent. It does not erase the injury.

SPEAKER_00 15:00

So what is the therapy actually aiming to do then?

SPEAKER_01 15:04

What it aims to do is provide the body with a more receptive cellular foundation. It provides the cellular fuel, but physical therapy does the actual heavy lifting of retraining the brain and muscles.

SPEAKER_00 15:14

Oh, I see. Without the physical rehabilitation to take advantage of that newly optimized cellular environment, the potential gains are severely limited.

SPEAKER_01 15:22

Exactly. You have to put in the work.

SPEAKER_00 15:24

Now, if a family is considering this path, the internet can be a truly terrifying place, filled with unregulated clinics making wild, guaranteed promises. Based on the sources we have, let's build a concrete survival guide checklist for you to evaluate any regenerative medicine program. How do families make a decision based on facts, not promises?

SPEAKER_01 15:44

Well, the sources outline a very clear, actionable framework. First, review the actual scientific evidence. Ask for peer-reviewed studies and clinical trial data, not marketing brochures or anecdotal testimonials.

SPEAKER_00 15:58

Right. Get the real data. What's step two?

SPEAKER_01 16:00

Second, demand a regulated clinical environment. You must verify those laboratory standards we discussed. You want to see CGMP compliance, sterile processing, and strict quality control.

SPEAKER_00 16:10

And third, you need to require absolute transparency regarding the cell types. You need to know exactly what is being administered.

SPEAKER_01 16:16

Yes. Are they ethically sourced, early passage umbilical cord cells, or is the clinic vague about their origins and processing methods?

SPEAKER_00 16:24

Good point. What's next?

SPEAKER_01 16:25

Fourth, understand the full scope of costs and the long-term follow-up plan. True regenerative medicine requires ongoing monitoring and integration with a patient's existing physical therapy team back home.

SPEAKER_00 16:38

So it's a long-term medical journey, not a vacation procedure.

SPEAKER_01 16:41

Definitely not a vacation.

SPEAKER_00 16:42

Yeah.

SPEAKER_01 16:43

And finally, seek out transparent, honest medical advice.

SPEAKER_00 16:47

A reputable clinic will carefully evaluate a child's specific medical history and will honestly tell a patient if they are unlikely to benefit from the program.

SPEAKER_01 16:56

Exactly. If a clinic guarantees a miracle, walk away. They must prioritize long-term patient trust and compassionate, realistic care over just securing a procedure.

SPEAKER_00 17:05

So to synthesize all of this for you, the honest answer to whether stem cells can improve movement in children with cerebral palsy involves a really delicate balance of genuine hope and strict caution.

SPEAKER_01 17:15

Yes, hope and caution.

SPEAKER_00 17:17

It is an emerging scientific field demonstrating real, measurable potential to improve quality of life. But those gains are only possible in highly controlled, heavily regulated environments.

SPEAKER_01 17:27

And it requires immense patience, unrelenting physical therapy, and strict medical oversight to actually see those results.

SPEAKER_00 17:34

It really forces us to reconsider how we approach healing itself.

SPEAKER_01 17:38

It does. For decades, modern medicine has searched for miracle cures, you know, a pill or a procedure that essentially does all the work for us, wiping away a complex condition overnight.

SPEAKER_00 17:50

But what if the true future of medicine isn't about overriding or replacing the body's hard work? What if it is simply about providing the precise cellular environment the body needs to make human resilience, physical therapy, and rehabilitation vastly more effective?

SPEAKER_01 18:05

That is the big question. Viewing stem cells as an incredibly powerful adjunct rather than a standalone cure completely changes the way we think about the human body's capacity to adapt and heal.

SPEAKER_00 18:16

We aren't throwing away the complex reality of physical rehabilitation. We're just making sure the body finally has the cellular power it needs to get the signal through. Thank you so much for joining us on this deep dive into the fascinating, evolving world of regenerative medicine. We appreciate you learning alongside us, and we will catch you next time.